Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Extrinsic and Intrinsic Pathways of Hemostasis01:20

Extrinsic and Intrinsic Pathways of Hemostasis

Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which forms a...
Disorders of Hemostasis01:24

Disorders of Hemostasis

Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Venous Thrombosis I: Introduction01:30

Venous Thrombosis I: Introduction

Venous thrombosis, the most common disorder of the veins, involves the formation of a thrombus or blood clot associated with vein inflammation. It can be classified as either superficial vein thrombosis or deep vein thrombosis.Superficial Vein Thrombosis: This involves the formation of a thrombus in a superficial vein, usually the greater or lesser saphenous vein. Though less severe than deep vein thrombosis (DVT), SVT can lead to complications if untreated.Deep Vein Thrombosis (DVT): This...
Introduction to Hemostasis01:05

Introduction to Hemostasis

Hemostasis is a complex physiological process that prevents excessive bleeding when a blood vessel is injured. It's crucial for maintaining the integrity of the circulatory system, as it ensures that our blood remains fluid while still within the vascular network and yet clots to prevent blood loss upon vessel injury.
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized, and...
Coagulation01:09

Coagulation

The coagulation phase is a critical part of the body's process to prevent blood loss following injury to blood vessels. It involves chemical reactions that form a clot to seal the injured area. The clotting process begins shortly after injury, within 15-20 seconds for severe damage and 1-2 minutes for minor injuries.
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...
Coagulation01:06

Coagulation

Colloidal solids are solid particles suspended in solution. They are usually negatively charged, attracting a compact primary layer of positively charged ions, which attract more counterions to form an electrical double layer. Electrostatic repulsion between the charged double layers prevents the particles from colliding, stabilizing the colloids. These solids are often undesirable because they can contain toxins that are difficult to remove. Coagulation is a technique that helps aggregate and...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Development and validation of a snakebite severity score for canine Daboia palaestinae envenomation: A prospective multicenter study.

Toxicon : official journal of the International Society on Toxinology·2026
Same author

Continuous Renal Replacement Therapy: Application of Kidney Disease Improving Global Outcomes Guidelines for Treatment Prescription in Dogs With Acute Kidney Injury and Outcome Prediction.

Journal of veterinary internal medicine·2025
Same author

Blood Carboxyhemoglobin Concentrations as a Diagnostic Biomarker of Hemolytic Anemias in Cats.

Journal of veterinary internal medicine·2025
Same author

Urinary Cystatin B as a marker of acute kidney injury in cats.

Veterinary journal (London, England : 1997)·2024
Same author

Serum chemistry, thyroxine concentration, and blood cell morphology of wild, young Blackchin Guitarfish Glaucostegus cemiculus sampled on the eastern Mediterranean coastline.

Journal of aquatic animal health·2024
Same author

Thromboelastometry for assessment of hemostasis and disease severity in 42 dogs with naturally-occurring heatstroke.

Journal of veterinary internal medicine·2024
Same journal

Clinical snapshot: Dripping fluid from the prepuce of a paint horse.

Compendium (Yardley, PA)·2013
Same journal

Feline focus: Diagnostic testing for feline thyroid disease: hypothyroidism.

Compendium (Yardley, PA)·2013
Same journal

Feline focus: Diagnostic testing for feline thyroid disease: hyperthyroidism.

Compendium (Yardley, PA)·2013
Same journal

Heatstroke: clinical signs, diagnosis, treatment, and prognosis.

Compendium (Yardley, PA)·2013
Same journal

Clinical snapshot: equine lymphoma.

Compendium (Yardley, PA)·2013
Same journal

Feline small cell lymphosarcoma versus inflammatory bowel disease: treatment and prognosis.

Compendium (Yardley, PA)·2013
See all related articles

Related Experiment Video

Updated: May 11, 2026

Measurement of Factor V Activity in Human Plasma Using a Microplate Coagulation Assay
13:08

Measurement of Factor V Activity in Human Plasma Using a Microplate Coagulation Assay

Published on: September 9, 2012

Disseminated intravascular coagulation.

Yaron Bruchim1, Itamar Aroch, Joseph Saragusty

  • 1The Hebrew University of Jerusalem, Israel.

Compendium (Yardley, PA)
|May 25, 2013
PubMed
Summary
This summary is machine-generated.

Disseminated intravascular coagulation (DIC) is a critical condition causing organ failure and bleeding. This review covers DIC pathophysiology, diagnosis, and treatment in dogs and cats, including new experimental approaches.

More Related Videos

In Vitro Microfluidic Disease Model to Study Whole Blood-Endothelial Interactions and Blood Clot Dynamics in Real-Time
09:19

In Vitro Microfluidic Disease Model to Study Whole Blood-Endothelial Interactions and Blood Clot Dynamics in Real-Time

Published on: May 24, 2020

A Microfluidic Flow Chamber Model for Platelet Transfusion and Hemostasis Measures Platelet Deposition and Fibrin Formation in Real-time
09:38

A Microfluidic Flow Chamber Model for Platelet Transfusion and Hemostasis Measures Platelet Deposition and Fibrin Formation in Real-time

Published on: February 14, 2017

Related Experiment Videos

Last Updated: May 11, 2026

Measurement of Factor V Activity in Human Plasma Using a Microplate Coagulation Assay
13:08

Measurement of Factor V Activity in Human Plasma Using a Microplate Coagulation Assay

Published on: September 9, 2012

In Vitro Microfluidic Disease Model to Study Whole Blood-Endothelial Interactions and Blood Clot Dynamics in Real-Time
09:19

In Vitro Microfluidic Disease Model to Study Whole Blood-Endothelial Interactions and Blood Clot Dynamics in Real-Time

Published on: May 24, 2020

A Microfluidic Flow Chamber Model for Platelet Transfusion and Hemostasis Measures Platelet Deposition and Fibrin Formation in Real-time
09:38

A Microfluidic Flow Chamber Model for Platelet Transfusion and Hemostasis Measures Platelet Deposition and Fibrin Formation in Real-time

Published on: February 14, 2017

Area of Science:

  • Veterinary Medicine
  • Hematology

Background:

  • Disseminated intravascular coagulation (DIC) is a life-threatening condition.
  • It is a secondary complication of various underlying disorders.
  • DIC involves excessive clotting, leading to organ damage and paradoxical bleeding.

Purpose of the Study:

  • To provide a comprehensive overview of DIC in veterinary medicine.
  • To discuss the pathophysiology, diagnosis, and treatment of DIC in dogs and cats.
  • To highlight novel and experimental diagnostic and therapeutic strategies for DIC.

Main Methods:

  • Literature review and synthesis of current knowledge on DIC.
  • Discussion of established and emerging diagnostic criteria and laboratory tests.
  • Analysis of current and experimental treatment modalities for DIC.

Main Results:

  • DIC is characterized by widespread microthromboses, organ dysfunction, and consumption of clotting factors.
  • Diagnosis relies on clinical signs and laboratory findings, often requiring interpretation of multiple parameters.
  • Treatment strategies aim to manage the underlying cause, support organ function, and modulate coagulation.

Conclusions:

  • DIC is a complex and severe condition requiring prompt recognition and management in veterinary patients.
  • Understanding the pathophysiology is crucial for effective diagnosis and treatment.
  • Ongoing research into novel diagnostics and therapeutics offers potential for improved outcomes in canine and feline DIC.